Skip to main content
. 2007 Sep 26;15(1):88–95. doi: 10.1245/s10434-007-9582-6

TABLE 4.

Tumor regression grade (TRG) of patients treated with neoadjuvant chemoradiation and surgery

TRGa No. of patients (%)
1—Absence of histologically identifiable residual cancer and fibrosis extending through the different layers of the esophageal wall 18 (38.3)
2—Presence of rare residual cancer cells scattered through the fibrosis 11 (23.4)
3—Increase in the number of residual cancer cells, but fibrosis still predominated 9 (19.1)
4—Residual cancer outgrowing fibrosis 7 (14.9)
5—Absence of regressive changes 2 (4.3)

a TRG according to Mandard et al.17